Freeze! Avoid Catastrophic Project Delays Caused by Formulation Changes
A white paper by John G. Augustine, PhD, SP Formulations
For pharmaceutical manufacturing companies, every decision in the product development process can impact the project outcome. By working closely with a reliable Contract Research Organization, clients can take the necessary precautions to avoid risks throughout the development program.
A white paper from SP Formulations, titled “Freeze! Avoid Catastrophic Project Delays Caused by Formulation Changes”, presents some of the problems associated with ‘simple’ formulation changes.
In addition to providing guidance on outsourcing drug development needs, the white paper, written by John G. Augustine, PhD, Formulations Manager at SP Formulations, also presents a case study detailing the alternative methods available for formulating a lyophilized product.
